BI-69A11
目录号 : KE7650
CAS No. : 1233322-09-2
纯度 : ≥95%
BI-69A11 is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
生物活性 |
BI-69A11 is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
|
分子式 |
C25H16ClN3O2
|
分子量 |
425.87
|
CAS号 |
1233322-09-2
|
运输条件 |
Room temperature in continental US; may vary elsewhere.
|
储存方式 |
Store at -20˚C
|